Molecular Signatures for Diagnosing Scleroderma
The present invention features methods for classifying, determining severity, and predicting clinical endpoints of scleroderma based upon the expression of selected biomarker genes.
WHITFIELD MICHAEL L [US]; SARGENT JENNIFER L [US]; PENDERGRASS SARAH A [US]; MILANO AUSRA [US]
Type of Offer:
« More Biotech Patents